Senthil Sundaram's Insider Trades & SAST Disclosures

Senthil Sundaram's most recent trade in Terns Pharmaceuticals Inc was a trade of 900,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Terns Pharmaceuticals Inc
Senthil Sundaram Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 900,000 900,000 - - Stock Option (Right to Buy)
Terns Pharmaceuticals Inc
Senthil Sundaram Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.33 per share. 01 Feb 2023 3 7,659 - 1.3 4 Common Stock
Terns Pharmaceuticals Inc
Senthil Sundaram Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.47 per share. 31 May 2022 7,656 7,656 - 1.5 11,254 Common Stock
Terns Pharmaceuticals Inc
Senthil Sundaram Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 315,000 315,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades